Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 3,848.0 | $507K | 0.36% | +114.0 | +3.0% | $131.74 | +18.0% |
| 2 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 7,000.0 | $491K | 0.35% | +481.0 | +7.4% | $70.15 | -7.6% |
| 3 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 15,000.0 | $488K | 0.34% | +286.0 | +1.9% | $32.54 | -9.5% |
| 4 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 1,465.0 | $485K | 0.34% | +147.0 | +11.2% | $330.87 | -9.2% |
| 5 | — | NEWAMSTERDAM PHARMA COMPANY | — | 15,000.0 | $480K | 0.34% | +80.0 | +0.5% | $32.01 | — |
| 6 | ARGX | ARGENX SE | Healthcare | 641.0 | $468K | 0.33% | +11.0 | +1.8% | $730.25 | +11.8% |
| 7 | — | INHIBRX BIOSCIENCES INC | — | 6,927.0 | $466K | 0.33% | +538.0 | +8.4% | $67.23 | — |
| 8 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 19,700.0 | $464K | 0.33% | +984.0 | +5.3% | $23.56 | -10.8% |
| 9 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 15,141.0 | $457K | 0.32% | +717.0 | +5.0% | $30.15 | -0.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%